Search - tctmd.com

Displaying 21 - 40 of 100

Sort: Relevancy | Date

News Conference News CRT 2023

New Durability Definitions Still Give Self-Expanding TAVI an Edge vs SAVR

Yael L. Maxwell

March 03, 2023

News Features

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

Michael O'Riordan

January 06, 2023

News Conference News TCT 2022

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

L.A. McKeown

September 23, 2022

News Conference News TCT 2022

Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances

Caitlin E. Cox

September 19, 2022

News Conference News TCT 2022

Surgical TAVI Explants Are Risky and Rising: STS Data Carry a Warning

Shelley Wood

September 19, 2022

Presentation TCT 2022

Bioprosthetic Valve Failure and Durability—Does TAVR Really Outperform SAVR?

Presenter: Michael Reardon

September 19, 2022

Presentation TCT 2022

Portico with FlexNav Introduction & Current Data

Presenter: Michael Reardon

September 17, 2022

Presentation TVT 2022

POINT: The Interaction Between Echo Hemodynamics and Structural Aortic Valve Deterioration

Presenter: Michael J. Reardon

June 09, 2022

Presentation TVT 2022

Acurate Neo2: Update From the ACURATE IDE and Related Studies

Presenter: Michael J. Reardon

June 08, 2022

Presentation TVT 2022

Avoiding PVL by Valve design in the Younger Patients

Presenter: Michael Reardon

June 08, 2022

Presentation TVT 2022

Hemodynamics and the Impact For Younger Patients

Presenter: Michael Reardon

June 08, 2022

Presentation TVT 2022

Evidence of Structural Valve Deterioration After TAVI: Recent Echo Findings

Presenter: Michael J. Reardon

June 08, 2022

News Conference News ACC 2022

Tricuspid Repair With Pascal Safe, Effective at 1 Year: CLASP TR

Yael L. Maxwell

April 05, 2022

Presentation ACC 2022

5-Year Incidence, Outcomes and Predictors of Structural Valve Deterioration of Transcatheter and Surgical Aortic Bioprostheses: Insights from the CoreValve US Pivotal and SURTAVI Trials

Presenter: Michael J. Reardon

April 04, 2022

News Conference News ACC 2022

Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years

Michael O'Riordan

April 04, 2022

Presentation TCT 2021

DurAVR THV: A Novel 3D Single Piece Valve Designed for Improved Durability and Hemodynamics

Presenter: Samir Kapadia

November 05, 2021

News Daily News

TAVR Yields Similar Success in Failed TAVR or Surgical Valves

Caitlin E. Cox

January 07, 2021

News Daily News

SAVR After Failed TAVR: Rare and Risky, Registry Study Finds

Yael L. Maxwell

June 10, 2020

News Conference News CRT 2020

Positive Early Data for TAVR in Low-Risk Patients With Bicuspid Valves

Michael O'Riordan

February 27, 2020

News Daily News

FDA Expands TAVR Indication to Low-Risk Patients

Michael O'Riordan

August 16, 2019

Advertisement

New Durability Definitions Still Give Self-Expanding TAVI an Edge vs SAVR

Major TAVI Studies Have ‘Methodological Issues,’ INTEGRITTY Group Contends

Pre-AVR Cardiac Damage in PARTNER Patients Linked to Poorer QoL at 1 Year

Mix of Patient, Procedural, and Device Factors All Drove TAVI Advances

Surgical TAVI Explants Are Risky and Rising: STS Data Carry a Warning

Bioprosthetic Valve Failure and Durability—Does TAVR Really Outperform SAVR?

Portico with FlexNav Introduction & Current Data

POINT: The Interaction Between Echo Hemodynamics and Structural Aortic Valve Deterioration

Acurate Neo2: Update From the ACURATE IDE and Related Studies

Avoiding PVL by Valve design in the Younger Patients

Hemodynamics and the Impact For Younger Patients

Evidence of Structural Valve Deterioration After TAVI: Recent Echo Findings

Tricuspid Repair With Pascal Safe, Effective at 1 Year: CLASP TR

5-Year Incidence, Outcomes and Predictors of Structural Valve Deterioration of Transcatheter and Surgical Aortic Bioprostheses: Insights from the CoreValve US Pivotal and SURTAVI Trials

Self-Expanding TAVI Looks More Durable Than SAVR at 5 Years

DurAVR THV: A Novel 3D Single Piece Valve Designed for Improved Durability and Hemodynamics

TAVR Yields Similar Success in Failed TAVR or Surgical Valves

SAVR After Failed TAVR: Rare and Risky, Registry Study Finds

Positive Early Data for TAVR in Low-Risk Patients With Bicuspid Valves

FDA Expands TAVR Indication to Low-Risk Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content